Source:http://linkedlifedata.com/resource/pubmed/id/11287234
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-4-5
|
pubmed:abstractText |
Currently, the production of therapeutic recombinant proteins relies heavily on the large-scale culture of eukaryotic cells that secrete the protein of interest into the media. It has been recognized that programmed cell death, or apoptosis, may pose a significant hurdle to maximum productivity in such systems. With a greater understanding of the molecular events causing apoptosis, alterations can be made to the cells and culture conditions to prevent apoptosis and enhance volumetric productivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0958-1669
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-9
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading | |
pubmed:year |
2001
|
pubmed:articleTitle |
Understanding and modulating apoptosis in industrial cell culture.
|
pubmed:affiliation |
Genetics Institute/Wyeth-Ayerst Research, Cell and Molecular Sciences, 1 Burtt Road, Andover, MA 01810, USA. hlaken@genetics.com
|
pubmed:publicationType |
Journal Article,
Review
|